Croda International Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Croda International de 25% y 4.8% por año respectivamente. Se prevé que el BPA crezca en un 25.2% al año. Se espera que la rentabilidad financiera sea de 11.7% en 3 años.
Información clave
25.0%
Tasa de crecimiento de los beneficios
25.20%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Chemicals | 39.3% |
| Tasa de crecimiento de los ingresos | 4.8% |
| Rentabilidad financiera futura | 11.74% |
| Cobertura de analistas | Good |
| Última actualización | 13 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • May 17
CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Future P/E Expectations
Analysts have adjusted their price targets on Croda International to around £32.80. This reflects updated assumptions on revenue growth, profit margins and future P/E multiples following a series of recent rating upgrades and target tweaks across the Street.
Actualización de narrativa • May 01
CRDA: Cluster Of Recent Upgrades Will Support Re Rating Potential
The updated analysis trims Croda International's fair value estimate slightly to £47.67 from £47.96, as analysts factor in recent target changes and upgrades that reflect adjusted assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts adjusting ratings and targets in quick succession.Actualización de narrativa • Apr 17
CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Fair Value Outlook
Analysts have raised their fair value estimate for Croda International from £23.00 to £28.65, citing recent upgrades, higher price targets, and updated assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International shows a mix of supportive and cautious views, with several firms revisiting their ratings and price targets in quick succession.Actualización de narrativa • Apr 02
CRDA: Recent Upgrades And Higher 3,280 Price Level Will Support Re Rating
Analysts have nudged their fair value estimate for Croda International slightly lower to about £47.96 from £48.16, reflecting modest adjustments to discount rate, revenue growth, profit margin and future P/E assumptions, alongside mixed but generally constructive recent research, including both target cuts and upgrades. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts updating their views through rating changes and revised price targets.Actualización de narrativa • Mar 19
CRDA: Higher Price Move To 3,280 And Modest P/E Reset Signal Upside
Narrative Update The analyst price target for Croda International has been raised to £3,280, an increase of £250. Analysts reference recent target moves from major banks, along with small adjustments to revenue growth, profit margin, discount rate and future P/E assumptions.Actualización de narrativa • Mar 05
CRDA: Higher Price References And Modest P/E Reset Will Support Upside Potential
Narrative Update The analyst price target for Croda International has been raised. Our fair value estimate has moved slightly higher to reflect recent increases in Street targets to around £32 per share, supported by analysts pointing to updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations.
Actualización de narrativa • Feb 19
CRDA: Higher Fair Value Assumptions Will Drive Reappraisal Of Margin Resilience
Analysts have raised their price target on Croda International by £4.00. This reflects updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following recent research updates.Actualización de narrativa • Feb 05
CRDA: Refined Assumptions And Lower P/E Will Support Higher Share Price
Analysts have trimmed their price target for Croda International by a small amount, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Valuation Changes Fair Value: trimmed slightly from £48.67 to £48.04 per share.Actualización de narrativa • Jan 21
CRDA: Activist Pressure Will Drive Reappraisal Of Margin Resilience And Future Re Rating
Analysts have trimmed their price target for Croda International to £34.02 from £34.46, reflecting slightly more cautious assumptions on revenue growth and profit margin, along with a modestly higher discount rate and a higher future P/E multiple. Valuation Changes Fair Value Estimate: trimmed slightly to £34.02 from £34.46.Artículo de análisis • Jan 21
Is There An Opportunity With Croda International Plc's (LON:CRDA) 26% Undervaluation?
Key Insights Croda International's estimated fair value is UK£35.97 based on 2 Stage Free Cash Flow to Equity Current...Actualización de narrativa • Jan 06
CRDA: Refreshed Q4 Guidance And Earnings Outlook Will Support Higher Share Price
Croda International's updated analyst price target has moved slightly higher, with recent revisions in the range of £30.50 to £33.00 per share, supported by analysts' refreshed assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research shows a cluster of modestly higher fair value views for Croda International, with price targets in a relatively tight range of £30.50 to £33.00 per share.Artículo de análisis • Jan 06
Croda International Plc's (LON:CRDA) Popularity With Investors Is Clear
With a price-to-earnings (or "P/E") ratio of 27.2x Croda International Plc ( LON:CRDA ) may be sending very bearish...Actualización de narrativa • Dec 17
CRDA: Activist Pressure Will Drive Future Reappraisal Of Margin Resilience
The analyst price target for Croda International has edged higher to approximately £31.00. This reflects modest improvements in forecast growth and valuation multiples as analysts point to stabilizing end markets and potential upside from strategic and activist driven initiatives, despite mixed target revisions across the Street.Artículo de análisis • Dec 05
Should You Investigate Croda International Plc (LON:CRDA) At UK£26.70?
Croda International Plc ( LON:CRDA ), is not the largest company out there, but it received a lot of attention from a...Actualización de narrativa • Dec 03
CRDA: Activist Pressure Will Drive A Reappraisal Of Margin Resilience
Analysts have nudged up their price target on Croda International by about £1, placing it in the low £30s per share. They point to a stabilizing outlook, reflected in modestly higher Street targets and expectations that prior commoditization concerns may have been overstated.Artículo de análisis • Nov 20
Is Croda International (LON:CRDA) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Actualización de narrativa • Nov 18
CRDA: Activist Pressure And Commoditization Concerns Will Shape The Next Share Move
Croda International's analyst price target has seen a modest upward revision to 3,150 GBp from 3,000 GBp. This reflects analysts' view that recent sector updates and firm-specific catalysts support a slightly higher fair value for the shares. Analyst Commentary Recent research updates on Croda International have highlighted a mix of optimism and caution.Actualización de narrativa • Nov 03
CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year
Croda International's analyst price target has been modestly raised, with the new consensus target increasing to approximately £31.00 from £30.00. Analysts cite slight improvements in revenue growth expectations and a lower discount rate as reasons for the update.Actualización de narrativa • Oct 20
Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Croda International's analyst consensus price target has seen a modest uptick, rising by £0.50 to £31.00. Analysts cite improved profit margins as offsetting softer revenue growth expectations.Artículo de análisis • Oct 06
Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...Actualización de narrativa • Oct 03
Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Analysts have revised Croda International's price target downward from £36.00 to £31.00, citing shifts in fair value and an improving revenue growth outlook. Ongoing activist pressures are seen as a potential positive for shares despite persistent margin concerns.Artículo de análisis • Sep 18
Croda International Plc's (LON:CRDA) P/E Is On The Mark
With a price-to-earnings (or "P/E") ratio of 25.7x Croda International Plc ( LON:CRDA ) may be sending very bearish...Actualización de narrativa • Sep 14
Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Croda International’s consensus price target saw a modest reduction to £35.23 as both future P/E and revenue growth expectations remained stable. What's in the News Croda International is prioritizing organic investment with a focus on higher returns, risk management, and faster cash payback, while reducing CapEx as a percentage of sales from 2026 onwards.Artículo de análisis • Aug 15
Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly
LSE:CRDA 1 Year Share Price vs Fair Value Explore Croda International's Fair Values from the Community and select yours...Artículo de análisis • Jul 12
Croda International Plc's (LON:CRDA) Intrinsic Value Is Potentially 35% Above Its Share Price
Key Insights Croda International's estimated fair value is UK£40.28 based on 2 Stage Free Cash Flow to Equity Croda...
Nueva narrativa • Mar 02
Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 1,943 | 247 | 249 | 351 | 11 |
| 12/31/2027 | 1,857 | 215 | 211 | 318 | 13 |
| 12/31/2026 | 1,775 | 177 | 153 | 269 | 13 |
| 12/31/2025 | 1,699 | 62 | 167 | 287 | N/A |
| 9/30/2025 | 1,684 | 101 | 119 | 254 | N/A |
| 6/30/2025 | 1,668 | 140 | 72 | 221 | N/A |
| 3/31/2025 | 1,648 | 149 | 105 | 270 | N/A |
| 12/31/2024 | 1,628 | 159 | 138 | 319 | N/A |
| 9/30/2024 | 1,629 | 161 | 163 | 354 | N/A |
| 6/30/2024 | 1,630 | 163 | 189 | 388 | N/A |
| 3/31/2024 | 1,662 | 167 | 169 | 363 | N/A |
| 12/31/2023 | 1,695 | 171 | 149 | 338 | N/A |
| 9/30/2023 | 1,769 | 182 | 172 | 355 | N/A |
| 6/30/2023 | 1,843 | 194 | 196 | 373 | N/A |
| 3/31/2023 | 1,966 | 422 | 176 | 340 | N/A |
| 12/31/2022 | 2,089 | 649 | 156 | 308 | N/A |
| 9/30/2022 | 2,086 | 680 | 151 | 297 | N/A |
| 6/30/2022 | 2,083 | 711 | 145 | 286 | N/A |
| 3/31/2022 | 1,986 | 516 | 167 | 317 | N/A |
| 12/31/2021 | 1,890 | 321 | 189 | 348 | N/A |
| 9/30/2021 | 1,771 | 284 | 166 | 322 | N/A |
| 6/30/2021 | 1,651 | 247 | 144 | 296 | N/A |
| 3/31/2021 | 1,521 | 224 | 155 | 291 | N/A |
| 12/31/2020 | 1,390 | 202 | 166 | 287 | N/A |
| 9/30/2020 | 1,363 | 204 | N/A | N/A | N/A |
| 6/30/2020 | 1,336 | 207 | 181 | 299 | N/A |
| 3/31/2020 | 1,357 | 216 | 187 | 301 | N/A |
| 12/31/2019 | 1,378 | 224 | 193 | 304 | N/A |
| 9/30/2019 | 1,388 | 230 | N/A | N/A | N/A |
| 6/30/2019 | 1,399 | 235 | N/A | 278 | N/A |
| 3/31/2019 | 1,393 | 237 | N/A | 270 | N/A |
| 12/31/2018 | 1,387 | 239 | N/A | 262 | N/A |
| 9/30/2018 | 1,378 | 241 | N/A | 265 | N/A |
| 6/30/2018 | 1,369 | 244 | N/A | 269 | N/A |
| 3/31/2018 | 1,371 | 241 | N/A | 266 | N/A |
| 12/31/2017 | 1,373 | 237 | N/A | 263 | N/A |
| 9/30/2017 | 1,358 | 226 | N/A | 267 | N/A |
| 6/30/2017 | 1,342 | 214 | N/A | 272 | N/A |
| 3/31/2017 | 1,293 | 206 | N/A | 268 | N/A |
| 12/31/2016 | 1,244 | 197 | N/A | 264 | N/A |
| 9/30/2016 | 1,185 | 192 | N/A | 247 | N/A |
| 6/30/2016 | 1,126 | 187 | N/A | 230 | N/A |
| 3/31/2016 | 1,104 | 184 | N/A | 219 | N/A |
| 12/31/2015 | 1,082 | 181 | N/A | 208 | N/A |
| 9/30/2015 | 1,078 | 178 | N/A | 201 | N/A |
| 6/30/2015 | 1,074 | 175 | N/A | 194 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (25% al año) de CRDA es superior a la tasa de ahorro (3.4%).
Beneficios vs. Mercado: Se prevé que los beneficios (25% al año) de CRDA crezcan más rápidamente que el mercado UK (11.4% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de CRDA crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (4.8% al año) de CRDA crezcan más rápidamente que los del mercado UK (4.5% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 4.8% al año) de CRDA crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de CRDA sea baja dentro de 3 años (11.7%).
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/21 13:42 |
| Precio de las acciones al final del día | 2026/05/21 00:00 |
| Beneficios | 2025/12/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Croda International Plc está cubierta por 33 analistas. 13 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| James Knight | Barclays |
| Katie Richards | Barclays |
| Amy Lian | Barclays |